Loading clinical trials...
Loading clinical trials...
Pre-operative Intranasal Oxytocin for Enhancing Bariatric-induced Diabetes remissionPre-operative Intranasal Oxytocin for Enhancing Bariatric-induced Diabetes Remission
Conditions
Interventions
Oxytocin
placebo
Locations
1
Israel
Soroka Unuversity Medical Center
Beersheba, Israel
Start Date
January 9, 2020
Primary Completion Date
August 30, 2023
Completion Date
August 30, 2025
Last Updated
January 26, 2022
NCT07472881
NCT01143454
NCT07051005
NCT00001987
NCT07296484
NCT07480161
Lead Sponsor
Soroka University Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions